Vitls Gets FDA Clearance for Vital Sign Monitoring System

Vitls has obtained 510(k) clearance from the FDA for its Vitls Platform, a system used for the remote monitoring of patient vital signs.

The platform uses an app on a single device to remotely monitor the vital signs of patients wearing a small, accompanying device. It can track patients’ vital signs both at home and in the hospital.

The accompanying wearable device sends data to the cloud for storage and distribution to hospital systems, the Vitls app and other connected devices.